Waddell & Reed Financial’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Waddell & Reed Financial’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-227,400	Closed	-$3.18M	–	570
2017 Q4	$3.18M	Hold	227,400	–	–	0.01%	488
2017 Q3	$3.82M	Hold	227,400	–	–	0.01%	482
2017 Q2	$3.83M	Buy	227,400 +5,200	+2%	+$77.7K	0.01%	496
2017 Q1	$3.44M	Hold	222,200	–	–	0.01%	501
2016 Q4	$3.32M	Sell	222,200 -28,100	-11%	-$394K	0.01%	528
2016 Q3	$3.14M	Hold	250,300	–	–	0.01%	553
2016 Q2	$2.25M	Hold	250,300	–	–	﹤0.01%	556
2016 Q1	$2.48M	Hold	250,300	–	–	﹤0.01%	567
2015 Q4	$2.88M	Buy	250,300 +53,900	+27%	+$667K	﹤0.01%	555
2015 Q3	$2.65M	Buy	+196,400	New	+$2.66M	﹤0.01%	555

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Waddell & Reed Financial's OXFD Position: Q1 2018 in Review

Waddell & Reed Financial sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2018, closing a stake of 227,400 shares — an estimated $3.18M sold.

Waddell & Reed Financial first reported a position in OXFD in Q3 2015 and held it in 10 quarters. The position peaked at $3.83M in Q2 2017. 74 funds tracked by Wall St. Rank hold OXFD as of Q1 2018.

Waddell & Reed Financial reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2018 after selling out during the quarter.
Waddell & Reed Financial sold 227,400 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2018, an estimated $3.18M.
Waddell & Reed Financial first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2015 and held it in 10 quarters.
Waddell & Reed Financial's Oxford Immunotec Global PLC Ordinary Shares position peaked at $3.83M in Q2 2017.
74 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2018.

Based on Waddell & Reed Financial's 13F filing for Q1 2018, filed 15 May 2018.